Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29637730 | 0.89 | PRKCB (0.56) | PRKCBPAK4 | |
| SCHEMBL29637763 | 0.89 | PRKCB (0.56) | PRKCBPAK4 | |
| SCHEMBL29637748 | 0.82 | PRKCB (0.55) | PRKCBPAK4 | |
| SCHEMBL29637740 | 0.81 | PRKCB (0.53) | PRKCB | |
| SCHEMBL21179291 | 0.80 | PRKCB (0.53) | PRKCBPAK4 | |
| SCHEMBL29637731 | 0.80 | PRKCB (0.53) | PRKCBPAK4 | |
| SCHEMBL3326180 | 0.74 | PRKCB (1.00) | PRKCB | |
| SCHEMBL20503388 | 0.73 | PRKCB (1.00) | PRKCB | |
| SCHEMBL29637747 | 0.73 | PRKCB (1.00) | PRKCB | |
| SCHEMBL3323010 | 0.73 | PRKCB (1.00) | PRKCB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220202815-A1 | TREATMENT OF CANCER | MINGSIGHT PHARMACEUTICALS, INC. | 2022-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220202815-A1 | TREATMENT OF CANCER | PRKACB, PRKDC, PRKCH | PRKCB 4/4885PAK4 264/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.